To access the full text documents, please follow this link: http://hdl.handle.net/2445/101621
dc.contributor.author | Adan Puig, Ana |
---|---|
dc.contributor.author | Capella Arrondo, Maria del Mar |
dc.contributor.author | Prat, Gemma |
dc.contributor.author | Soriano Raya, Juan José |
dc.date | 2016-09-07T10:31:20Z |
dc.date | 2016-09-07T10:31:20Z |
dc.date | 2016-09 |
dc.identifier.uri | http://hdl.handle.net/2445/101621 |
dc.format | 3 p. |
dc.format | application/pdf |
dc.language.iso | cat |
dc.rights | cc-by-nc-nd (c) Adán Puig et al., 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ |
dc.subject | Antipsicòtics |
dc.subject | Assaigs clínics |
dc.subject | Psicofarmacologia |
dc.subject | Antipsychotic drugs |
dc.subject | Clinical trials |
dc.subject | Psychopharmacology |
dc.title | Disseny d’un assaig clínic (fase III) per valorar l’eficàcia de la metilzapina en l’esquizofrènia |
dc.type | info:eu-repo/semantics/workingPaper |
dc.description.abstract |